On 11 February, International Day of Women and Girls in Science, a new edition of the #100tífiques (100 female scientists) talks will be held, both i1
This analysis, the largest conducted to date and led by Hospital Clínic–IDIBAPS researchers, provides evidence of the inefficacy of this therapeutic1
Researchers from the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar) and the IIBB-CSIC-IDIBAPS have led the study, published in t1
The finding may make it possible to take therapeutic approaches that will increase the success rate of cognitive-behavioral therapy. This is the ther1
The new test, called HER2DX, analyzes RNA on 27 genes to predict survival outcomes and the likelihood that patients will respond to treatment.
Researchers at Hospital Clínic-IDIBAPS are leading the CIBERESUCICOVID project, which seeks to identify the risk and prognosis factors of patients wi1
Immunotherapy has revolutionized the treatment of hepatocellular carcinoma. Researchers from the Hospital Clínic-IDIBAPS have published a review in t1
The study shows how the average life of the virus is drastically reduced, in transplanted patients and cell cultures alike.
The inhibition of this molecule, in addition to reducing the predisposition towards developing the disease, also reduces the alteration of the microb1
The Hospital Clínic-IDIBAPS has developed the first CAR T-cell therapy in Europe to treat multiple myeloma, the second most common type of blood canc1
